))
Innovations in Type 1 Diabetes
Manage episode 423304019 series 3574590
Content provided by ACOFP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ACOFP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This episode of ACOFP's DO.fm Clinical podcast features Jay Shubrook, DO, FAAFP, FACOFP discussing Type 1 diabetes (T1D). We delve into the importance of screening and early intervention, the increasing prevalence in adults, the importance of patient-centered care and new and evolving technologies that are aiding in treatment and management of T1D.
Dr. Shubrook does disclose relationships with Abbott, Bayer and Novo Nordisk as a non-CE consultant and AstraZeneca, Eli Lilly and Novo Nordisk as an advisory board member. This podcast has been reviewed by non-conflicted physicians to ensure any potential conflicts are mitigated.
Mentioned in this episode:
3 episodes
Share
